Quantabio’s UltraPlex 1-Step ToughMix Added to SalivaDirect  - Emergency Use Authorization Protocol Quantabio’s UltraPlex 1-Step ToughMix Added to SalivaDirect - Emergency Use Authorization Protocol
Quantabio’s UltraPlex 1-Step ToughMix Added to SalivaDirect Emergency Use Authorization Protocol  Ready-to-use, one-step master mix increases SARS-CoV-2 RT-PCR assay efficiency, sensitivity and...
Read More
Introducing sparQ UDI Adapters Introducing sparQ UDI Adapters
Today we are launching our newest next generation sequencing product, sparQ UDI Adapters, to better enable you with a complete library prep solution for sequencing on Illumina platforms. sparQ UDI ...
Read More
Introducing NEW sparQ Universal Library Quant Kit Introducing NEW sparQ Universal Library Quant Kit
sparQ Universal Library Quant Kit provides rapid and accurate quantification of libraries prepared for sequencing on Illumina® NGS platforms. Accurate quantification of the number of amplifiable libr...
Read More
Launching NEW qScript 1-Step Virus ToughMix Launching NEW qScript 1-Step Virus ToughMix
qScript 1-Step Virus ToughMix is a 2x, ready-to-use, master mix for rapid detection of RNA viruses such as Flu-A, Flu-B, and SARS-CoV-2, using one-step, or single-tube reverse transcription quantitati...
Read More
Quantabio’s UltraPlex 1-Step ToughMix Continues to Enhance CDC Protocols to Detect and Differentiate COVID-19 and Influenza Respiratory Diseases Quantabio’s UltraPlex 1-Step ToughMix Continues to Enhance CDC Protocols to Detect and Differentiate COVID-19 and Influenza Respiratory Diseases
CDC’s latest emergency use authorization for influenza SARS-CoV-2 assay validates Quantabio’s ability to multiplex up to five targets with high efficiency, sensitivity and specificity BEVERLY, M...
Read More
Quantabio RT-qPCR ToughMix Given Expanded Role in CDC COVID-19 Testing Protocol Quantabio RT-qPCR ToughMix Given Expanded Role in CDC COVID-19 Testing Protocol
Amended CDC emergency use authorization recognizes UltraPlex formulation in an effective heat treatment alternative for RNA extraction BEVERLY, Mass. – July 1, 2020 – Quantabio, a leading provide...
Read More
CDC Adds Two Quantabio RT-qPCR ToughMix Kits to COVID-19 Diagnostic Testing Protocol CDC Adds Two Quantabio RT-qPCR ToughMix Kits to COVID-19 Diagnostic Testing Protocol
CDC Adds Two Quantabio RT-qPCR ToughMix Kits to COVID-19 Diagnostic Testing Protocol qScript XLT 1-Step RT-qPCR ToughMix and UltraPlex 1-Step ToughMix granted Emergency Use Authorization Quantabio...
Read More
Quantabio Joins Forces with BioLegend to Improve Sample Processing for Single-Cell RNA Expression and Proteomic Studies Quantabio Joins Forces with BioLegend to Improve Sample Processing for Single-Cell RNA Expression and Proteomic Studies
Highly efficient and reliable sparQ reagents enable TotalSeq™ customers to process up to 12 times more samples for the same cost as alternative products. Read the full story...
Read More
Quantabio to Showcase Industry’s Fastest qPCR-based NGS Library Quantification Kit and HiFi PCR Mix at American Society of Human Genetics Annual Meeting Quantabio to Showcase Industry’s Fastest qPCR-based NGS Library Quantification Kit and HiFi PCR Mix at American Society of Human Genetics Annual Meeting
Quantabio to Showcase Industry’s Fastest qPCR-based NGS Library Quantification Kit and HiFi PCR Mix at American Society of Human Genetics Annual Meeting Presentations to demonstrate company’s con...
Read More
Quantabio Continues Newborn Screening Expansion as Tech Adopted by Wisconsin State Program Quantabio Continues Newborn Screening Expansion as Tech Adopted by Wisconsin State Program
NEW YORK – Quantabio is expanding its footprint in the newborn screening market with an agreement from a Wisconsin public health lab to adopt the company's dried blood spot (DBS) extraction and qPCR...
Read More

1-10 of 21

Page:
  1. 1
  2. 2
  3. 3